Imaging the Alzheimer brain.

This supplement to the Journal of Alzheimer's Disease contains more than half of the chapters from The Handbook of Imaging the Alzheimer Brain, which was first presented at the International Conference on Alzheimer's Disease in Paris, in July, 2011. While the Handbook contains 27 chapters that are modified articles from 2009, 2010, and 2011 issues of the Journal of Alzheimer's Disease, this supplement contains the 31 new chapters of that book and an introductory article drawn from the introductions to each section of the book. The Handbook was designed to provide a multilevel overview of the full field of brain imaging related to Alzheimer's disease (AD). The Handbook, as well as this supplement, contains both reviews of the basic concepts of imaging, the latest developments in imaging, and various discussions and perspectives of the problems of the field and promising directions. The Handbook was designed to be useful for students and clinicians interested in AD as well as scientists studying the brain and pathology related to AD.

[1]  J. Morris,et al.  Functional deactivations: Change with age and dementia of the Alzheimer type , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[2]  M. Greicius,et al.  Default-mode network activity distinguishes Alzheimer's disease from healthy aging: Evidence from functional MRI , 2004, Proc. Natl. Acad. Sci. USA.

[3]  K. Coburn,et al.  Flash P2 delay in primary degenerative dementia of the Alzheimer type , 1995, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[4]  J. Yesavage,et al.  MR spectroscopy for assessment of memantine treatment in mild to moderate Alzheimer dementia. , 2011, Journal of Alzheimer's disease : JAD.

[5]  Andrew Simmons,et al.  Magnetic resonance imaging and magnetic resonance spectroscopy for detection of early Alzheimer's disease. , 2011, Journal of Alzheimer's disease : JAD.

[6]  Lisa T. Eyler,et al.  Verbal paired-associate learning by APOE genotype in non-demented older adults: fMRI evidence of a right hemispheric compensatory response , 2007, Neurobiology of Aging.

[7]  Thanh-Thu T. Tran,et al.  Mild cognitive impairment: evaluation with 4-T functional MR imaging. , 2006, Radiology.

[8]  Kelly O'Keefe,et al.  Evidence of Altered Posteromedial Cortical fMRI Activity in Subjects at Risk for Alzheimer Disease , 2010, Alzheimer disease and associated disorders.

[9]  S. Potkin,et al.  Genome-wide association study of CSF biomarkers Aβ1-42, t-tau, and p-tau181p in the ADNI cohort , 2010, Neurology.

[10]  S. Thibodeau,et al.  Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. , 1996, The New England journal of medicine.

[11]  D. Bennett,et al.  Loss and atrophy of layer II entorhinal cortex neurons in elderly people with mild cognitive impairment , 2001, Annals of neurology.

[12]  J. Ashford,et al.  Comparison of Neuropathologic Criteria for the Diagnosis of Alzheimer’s Disease , 1997, Neurobiology of Aging.

[13]  Charles D. Smith,et al.  Neuroimaging through the course of Alzheimer's disease. , 2010, Journal of Alzheimer's disease : JAD.

[14]  G. Alexander,et al.  Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome. , 2001, JAMA.

[15]  J. Hardy,et al.  The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .

[16]  D P Salmon,et al.  Patients with MCI and N400 or P600 abnormalities are at very high risk for conversion to dementia , 2008, Neurology.

[17]  Ulrich Seidl,et al.  Morphological cerebral correlates of CERAD test performance in mild cognitive impairment and Alzheimer's disease. , 2011, Journal of Alzheimer's disease : JAD.

[18]  N. Schuff,et al.  Relationship between CSF biomarkers of Alzheimer's disease and rates of regional cortical thinning in ADNI data. , 2011, Journal of Alzheimer's disease : JAD.

[19]  M. Albert,et al.  fMRI studies of associative encoding in young and elderly controls and mild Alzheimer’s disease , 2003, Journal of neurology, neurosurgery, and psychiatry.

[20]  G. Brewer,et al.  Is brain amyloid production a cause or a result of dementia of the Alzheimer's type? , 2010, Journal of Alzheimer's disease : JAD.

[21]  M. Yassa.  Searching for novel biomarkers using high resolution diffusion tensor imaging. , 2011, Journal of Alzheimer's disease : JAD.

[22]  Cindee M. Madison,et al.  Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI , 2011, Neurobiology of Aging.

[23]  M. Greicius,et al.  Prospects for Prediction , 2007, Annals of the New York Academy of Sciences.

[24]  F Träber,et al.  A multicenter 1H-MRS study of the medial temporal lobe in AD and MCI , 2009, Neurology.

[25]  M. Bobinski,et al.  The histological validation of post mortem magnetic resonance imaging-determined hippocampal volume in Alzheimer's disease , 1999, Neuroscience.

[26]  Kewei Chen,et al.  Alzheimer's Prevention Initiative: a plan to accelerate the evaluation of presymptomatic treatments. , 2011, Journal of Alzheimer's disease : JAD.

[27]  Nick C Fox,et al.  Reduced cortical thickness in the posterior cingulate gyrus is characteristic of both typical and atypical Alzheimer's disease. , 2010, Journal of Alzheimer's disease : JAD.

[28]  A Hofman,et al.  Hippocampal, amygdalar, and global brain atrophy in different apolipoprotein E genotypes , 2002, Neurology.

[29]  J. Wesson Ashford,et al.  Apolipoprotein E ɛ4 influences on episodic recall and brain structures in aging pilots , 2010, Neurobiology of Aging.

[30]  H. Soininen,et al.  Decreased hippocampal volume asymmetry on MRIs in nondemented elderly subjects carrying the apolipoprotein E ϵ4 allele , 1995, Neurology.

[31]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[32]  H. Braak,et al.  Diagnostic Criteria for Neuropathologic Assessment of Alzheimer’s Disease , 1997, Neurobiology of Aging.

[33]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[34]  Charles W Hoge,et al.  Mild traumatic brain injury in U.S. Soldiers returning from Iraq. , 2008, The New England journal of medicine.

[35]  P. Aupperle.  Navigating patients and caregivers through the course of Alzheimer's disease. , 2006, The Journal of clinical psychiatry.

[36]  S. de Santi,et al.  Pre-clinical detection of Alzheimer's disease using FDG-PET, with or without amyloid imaging. , 2010, Journal of Alzheimer's disease : JAD.

[37]  A. Brun,et al.  Regional pattern of degeneration in Alzheimer's disease: neuronal loss and histopathological grading , 1981, Histopathology.

[38]  Panteleimon Giannakopoulos,et al.  Face short-term memory-related electroencephalographic patterns can differentiate multi- versus single-domain amnestic mild cognitive impairment. , 2011, Journal of Alzheimer's disease : JAD.

[39]  J. Morris,et al.  The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[40]  P. Matthews,et al.  Distinct patterns of brain activity in young carriers of the APOE e4 allele , 2009, NeuroImage.

[41]  Jeff Kuret,et al.  Research towards tau imaging. , 2011, Journal of Alzheimer's disease : JAD.

[42]  Thomas E. Nichols,et al.  A multi-center randomized proof-of-concept clinical trial applying [¹⁸F]FDG-PET for evaluation of metabolic therapy with rosiglitazone XR in mild to moderate Alzheimer's disease. , 2011, Journal of Alzheimer's disease : JAD.

[43]  M. Pericak-Vance,et al.  Apolipoprotein E ∈4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases , 1993, The Lancet.

[44]  Cornelius Weiller,et al.  Reduced Precuneus Deactivation during Object Naming in Patients with Mild Cognitive Impairment, Alzheimer’s Disease, and Frontotemporal Lobar Degeneration , 2010, Dementia and Geriatric Cognitive Disorders.

[45]  M. Albert,et al.  Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD , 2005, Neurology.

[46]  K. Coburn,et al.  Electroencephalography in Neuropsychiatry , 2006 .

[47]  K. Coburn,et al.  Delayed Late Component of Visual Global Field Power in Probable Alzheimer's Disease , 1993, Journal of geriatric psychiatry and neurology.

[48]  G L Shulman,et al.  INAUGURAL ARTICLE by a Recently Elected Academy Member:A default mode of brain function , 2001 .

[49]  Magda Tsolaki,et al.  Combinatorial markers of mild cognitive impairment conversion to Alzheimer's disease--cytokines and MRI measures together predict disease progression. , 2011, Journal of Alzheimer's disease : JAD.

[50]  B. Caffo,et al.  Familial risk for Alzheimer's disease alters fMRI activation patterns. , 2006, Brain : a journal of neurology.

[51]  H. Braak,et al.  Frequency of Stages of Alzheimer-Related Lesions in Different Age Categories , 1997, Neurobiology of Aging.

[52]  Marina Boccardi,et al.  Survey of protocols for the manual segmentation of the hippocampus: preparatory steps towards a joint EADC-ADNI harmonized protocol. , 2011, Journal of Alzheimer's disease : JAD.

[53]  A. Ash,et al.  Implications of Comorbidity on Costs for Patients With Alzheimer Disease , 2008, Medical care.

[54]  J. Ghajar.  Traumatic brain injury , 2000, The Lancet.

[55]  Eva Meisenzahl,et al.  Altered brain activation during a verbal working memory task in subjects with amnestic mild cognitive impairment. , 2010, Journal of Alzheimer's disease : JAD.

[56]  K. Coburn,et al.  Electrocortical mapping, MRI, and neuropsychological measures: evidence of Alzheimer's disease in the presence of vascular lesions. , 1991, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

[57]  K. Blennow,et al.  Magnetic resonance imaging improves cerebrospinal fluid biomarkers in the early detection of Alzheimer's disease. , 2009, Journal of Alzheimer's disease : JAD.

[58]  A. Mauleon,et al.  Brain perfusion correlates of visuoperceptual deficits in mild cognitive impairment and mild Alzheimer's disease. , 2010, Journal of Alzheimer's disease : JAD.

[59]  Cristina Geroldi,et al.  Increase of theta/gamma and alpha3/alpha2 ratio is associated with amygdalo-hippocampal complex atrophy. , 2009, Journal of Alzheimer's disease : JAD.

[60]  Bradford C. Dickerson,et al.  Functional abnormalities of the medial temporal lobe memory system in mild cognitive impairment and Alzheimer's disease: Insights from functional MRI studies , 2008, Neuropsychologia.

[61]  G. Alexander,et al.  Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect. , 2009, The New England journal of medicine.

[62]  Susan Whitfield-Gabrieli,et al.  Cognitive training changes hippocampal function in mild cognitive impairment: a pilot study. , 2011, Journal of Alzheimer's disease : JAD.

[63]  A. Alzheimer.  Uber eine eigenartige Erkrankung der Hirnrinde , 1907 .

[64]  M. Roth,et al.  The Association Between Quantitative Measures of Dementia and of Senile Change in the Cerebral Grey Matter of Elderly Subjects , 1968, British Journal of Psychiatry.

[65]  C. Jack,et al.  Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade , 2010, The Lancet Neurology.

[66]  K. Coburn,et al.  P2 Flash Visual Evoked Response Delay May Be a Marker of Cognitive Dysfunction in Healthy Elderly Volunteers , 1996, International Psychogeriatrics.

[67]  Mark S. Cohen,et al.  Patterns of brain activation in people at risk for Alzheimer's disease. , 2000, The New England journal of medicine.

[68]  Igor Yakushev,et al.  Diffusion tensor imaging of the hippocampus in MCI and early Alzheimer's disease. , 2011, Journal of Alzheimer's disease : JAD.

[69]  A. Bruni,et al.  AbetaPP A713T mutation in late onset Alzheimer's disease with cerebrovascular lesions. , 2009, Journal of Alzheimer's disease : JAD.

[70]  L. Serpell,et al.  Structure and morphology of the Alzheimer's amyloid fibril , 2005, Microscopy research and technique.

[71]  G. d'Ydewalle,et al.  Controlled memory processes in questionable Alzheimer's disease: a view from neuroimaging research. , 2010, Journal of Alzheimer's disease : JAD.

[72]  Laura Hemmy,et al.  Evaluation and tracking of Alzheimer's disease severity using resting-state magnetoencephalography. , 2011, Journal of Alzheimer's disease : JAD.

[73]  J. Wesson Ashford,et al.  ApoE genotype accounts for the vast majority of AD risk and AD pathology , 2004, Neurobiology of Aging.

[74]  Yong He,et al.  Multiple diffusion indices reveals white matter degeneration in Alzheimer's disease and mild cognitive impairment: a tract-based spatial statistics study. , 2011, Journal of Alzheimer's disease : JAD.

[75]  C. Beaulieu,et al.  The basis of anisotropic water diffusion in the nervous system – a technical review , 2002, NMR in biomedicine.

[76]  G. Frisoni,et al.  SPECT predictors of cognitive decline and Alzheimer's disease in mild cognitive impairment. , 2009, Journal of Alzheimer's disease : JAD.

[77]  A. Furst,et al.  Amyloid-β and glucose metabolism in Alzheimer's disease. , 2011, Journal of Alzheimer's disease : JAD.

[78]  W. Martin,et al.  MR Spectroscopy in Neurodegenerative Disease , 2007, Molecular Imaging and Biology.

[79]  D. G. Clark,et al.  Brain Metabolic Correlates of Decision Making in Amnestic Mild Cognitive Impairment , 2010, Neuropsychology, development, and cognition. Section B, Aging, neuropsychology and cognition.

[80]  Jason R. Taylor,et al.  Cognitive event-related potentials: biomarkers of synaptic dysfunction across the stages of Alzheimer's disease. , 2011, Journal of Alzheimer's disease : JAD.

[81]  Evan Fletcher,et al.  Vascular and Degenerative Processes Differentially Affect Regional Interhemispheric Connections in Normal Aging, Mild Cognitive Impairment, and Alzheimer Disease , 2010, Stroke.

[82]  J. Coyle,et al.  Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. , 1982, Science.

[83]  J. Ashford,et al.  Neuropil Threads are Collinear With MAP2 Immunostaining in Neuronal Dendrites of Alzheimer Brain , 1998, Journal of neuropathology and experimental neurology.

[84]  L. Mucke,et al.  Amyloid-β/Fyn–Induced Synaptic, Network, and Cognitive Impairments Depend on Tau Levels in Multiple Mouse Models of Alzheimer's Disease , 2011, The Journal of Neuroscience.

[85]  D. Swaab,et al.  Aggravated decrease in the activity of nucleus basalis neurons in Alzheimer's disease is apolipoprotein E-type dependent. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[86]  C. Caltagirone,et al.  In vivo structural neuroanatomy of corpus callosum in Alzheimer's disease and mild cognitive impairment using different MRI techniques: a review. , 2010, Journal of Alzheimer's disease : JAD.

[87]  A. Roses.  An inherited variable poly-T repeat genotype in TOMM40 in Alzheimer disease. , 2010, Archives of neurology.

[88]  H. Eichenbaum.  A cortical–hippocampal system for declarative memory , 2000, Nature Reviews Neuroscience.

[89]  N. Schuff,et al.  Regional Myo-inositol Concentration in Mild Cognitive Impairment Using 1H Magnetic Resonance Spectroscopic Imaging , 2009, Alzheimer disease and associated disorders.

[90]  S. Rombouts,et al.  Altered resting state networks in mild cognitive impairment and mild Alzheimer's disease: An fMRI study , 2005, Human brain mapping.

[91]  Jonas Persson,et al.  Reduced hippocampal volume in non-demented carriers of the apolipoprotein E ɛ4: Relation to chronological age and recognition memory , 2006, Neuroscience Letters.

[92]  J. Fisk,et al.  An MRI brain atrophy and lesion index to assess the progression of structural changes in Alzheimer's disease, mild cognitive impairment, and normal aging: a follow-up study. , 2011, Journal of Alzheimer's disease : JAD.

[93]  Harald Hampel,et al.  White matter microstructure in relation to education in aging and Alzheimer's disease. , 2009, Journal of Alzheimer's disease : JAD.

[94]  Lars Bäckman,et al.  Apolipoprotein E and cognitive performance: a meta-analysis. , 2004, Psychology and aging.

[95]  Denise C. Park,et al.  Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[96]  P. Lewczuk,et al.  Nuclear medicine diagnostic techniques in the era of pathophysiology-based CSF biomarkers for Alzheimer's disease. , 2011, Journal of Alzheimer's disease : JAD.

[97]  J. Ashford,et al.  Screening for memory disorders, dementia and Alzheimer’s disease , 2008 .

[98]  Sterling C. Johnson,et al.  Effects of hypoperfusion in Alzheimer's disease. , 2011, Journal of Alzheimer's disease : JAD.

[99]  B. Miller,et al.  Cognition, glucose metabolism and amyloid burden in Alzheimer's disease , 2012, Neurobiology of Aging.

[100]  C. Cool,et al.  Single SPECT measures of cerebral cortical perfusion reflect time-index estimation of dementia severity in Alzheimer's disease. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[101]  Elisa R Braver,et al.  Understanding sequelae of injury mechanisms and mild traumatic brain injury incurred during the conflicts in Iraq and Afghanistan: persistent postconcussive symptoms and posttraumatic stress disorder. , 2008, American journal of epidemiology.

[102]  Dennis W. Duke,et al.  Altered EEG Dynamical Responsivity Associated with Normal Aging and Probable Alzheimer's Disease , 1991 .

[103]  Gregory J Brewer,et al.  Amyloid-β as a modulator of synaptic plasticity. , 2010, Journal of Alzheimer's disease : JAD.

[104]  Michael Erb,et al.  Hippocampal activation in patients with mild cognitive impairment is necessary for successful memory encoding , 2007, Journal of Neurology, Neurosurgery & Psychiatry.

[105]  J. Ashford,et al.  ApoE4: is it the absence of good or the presence of bad? , 2002, Journal of Alzheimer's disease : JAD.

[106]  E. Vittinghoff,et al.  Post-traumatic stress disorder and risk of dementia among U.S. veterans , 2009, Alzheimer's & Dementia.

[107]  P. Thompson,et al.  PET of brain amyloid and tau in mild cognitive impairment. , 2006, The New England journal of medicine.

[108]  D R Wekstein,et al.  Linguistic ability in early life and cognitive function and Alzheimer's disease in late life. Findings from the Nun Study. , 1996, JAMA.

[109]  Deanna Greenstein,et al.  Cortical morphology in children and adolescents with different apolipoprotein E gene polymorphisms: an observational study , 2007, The Lancet Neurology.

[110]  Charles DeCarli,et al.  Sex, Apolipoprotein E ε4 Status, and Hippocampal Volume in Mild Cognitive Impairment , 2005 .

[111]  M W Weiner,et al.  Evaluation of treatment effects in Alzheimer's and other neurodegenerative diseases by MRI and MRS , 2006, NMR in biomedicine.

[112]  A. McKee,et al.  Chronic Traumatic Encephalopathy in Athletes: Progressive Tauopathy After Repetitive Head Injury , 2009, Journal of neuropathology and experimental neurology.

[113]  K. Coburn,et al.  The value of quantitative electroencephalography in clinical psychiatry: a report by the Committee on Research of the American Neuropsychiatric Association. , 2006, The Journal of neuropsychiatry and clinical neurosciences.

[114]  G. Small,et al.  The merits of FDDNP-PET imaging in Alzheimer's disease. , 2011, Journal of Alzheimer's disease : JAD.

[115]  A. Ash,et al.  Healthcare costs and utilization for Medicare beneficiaries with Alzheimer's , 2008, BMC health services research.

[116]  E. Amaro,et al.  Use of SVM methods with surface-based cortical and volumetric subcortical measurements to detect Alzheimer's disease. , 2010, Journal of Alzheimer's disease : JAD.

[117]  D. Price,et al.  Cholinergic innervation in neuritic plaques. , 1982, Science.

[118]  R. Clark,et al.  The medial temporal lobe. , 2004, Annual review of neuroscience.

[119]  Beatriz Bosch,et al.  Greater default-mode network abnormalities compared to high order visual processing systems in amnestic mild cognitive impairment: an integrated multi-modal MRI study. , 2010, Journal of Alzheimer's disease : JAD.

[120]  G. E. Alexander,et al.  Activation of brain regions vulnerable to Alzheimer's disease: The effect of mild cognitive impairment , 2006, Neurobiology of Aging.

[121]  E. Barbeau,et al.  Impaired visual recognition memory in amnestic mild cognitive impairment is associated with mesiotemporal metabolic changes on magnetic resonance spectroscopic imaging. , 2011, Journal of Alzheimer's disease : JAD.

[122]  J. Yesavage,et al.  Ethical, and practical issues in applying functional imaging to the clinical management of Alzheimer’s disease , 2002, Brain and Cognition.

[123]  G. Kerchner.  Ultra-high field 7T MRI: a new tool for studying Alzheimer's disease. , 2011, Journal of Alzheimer's disease : JAD.

[124]  Maija Pihlajamäki,et al.  Functional MRI Assessment of Task-Induced Deactivation of the Default Mode Network in Alzheimer’s Disease and At-Risk Older Individuals , 2009, Behavioural neurology.

[125]  George Perry,et al.  Leptin: a novel therapeutic strategy for Alzheimer's disease. , 2009, Journal of Alzheimer's disease : JAD.

[126]  K. Lovblad,et al.  Individual prediction of cognitive decline in mild cognitive impairment using support vector machine-based analysis of diffusion tensor imaging data. , 2010, Journal of Alzheimer's disease : JAD.

[127]  H. Kraemer,et al.  Donepezil treatment and Alzheimer disease: can the results of randomized clinical trials be applied to Alzheimer disease patients in clinical practice? , 2007, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[128]  R. Stelzmann,et al.  An english translation of alzheimer's 1907 paper, “über eine eigenartige erkankung der hirnrinde” , 1995, Clinical anatomy.

[129]  J. Wesson Ashford,et al.  APOE genotype effects on alzheimer’s disease onset and epidemiology , 2007, Journal of Molecular Neuroscience.

[130]  O. Sabri,et al.  Florbetaben to trace amyloid-β in the Alzheimer brain by means of PET. , 2011, Journal of Alzheimer's disease : JAD.

[131]  M. Albert,et al.  DTI analyses and clinical applications in Alzheimer's disease. , 2011, Journal of Alzheimer's disease : JAD.

[132]  D. Knopman,et al.  Vascular risk factors: imaging and neuropathologic correlates. , 2010, Journal of Alzheimer's disease : JAD.

[133]  M. Albert,et al.  Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[134]  K. Coburn,et al.  Visual evoked potentials in dementia: selective delay of flash P2 in probable Alzheimer's disease. , 1991, The Journal of neuropsychiatry and clinical neurosciences.

[135]  S S Schochet,et al.  Neuropathology of aging. , 1998, Neurologic clinics.

[136]  M N Rossor,et al.  Correlation between rates of brain atrophy and cognitive decline in AD , 1999, Neurology.

[137]  F. Schmitt,et al.  Synaptic loss in the inferior temporal gyrus in mild cognitive impairment and Alzheimer's disease. , 2011, Journal of Alzheimer's disease : JAD.

[138]  D. Perl.  Neuropathology of Alzheimer's disease and related disorders. , 2000, Neurologic clinics.

[139]  Luke E Stoeckel,et al.  Magnetic Resonance Imaging Volume of the Angular Gyri Predicts Financial Skill Deficits in People with Amnestic Mild Cognitive Impairment , 2010, Journal of the American Geriatrics Society.

[140]  Cornelis J. Stam,et al.  Delayed rather than decreased BOLD response as a marker for early Alzheimer's disease , 2005, NeuroImage.

[141]  R. C. Hall,et al.  Focal signs and brain CT scan in psychiatric patients. , 1985, The New England journal of medicine.

[142]  H. R. Griffith,et al.  Proton magnetic resonance spectroscopy in dementias and mild cognitive impairment. , 2009, International review of neurobiology.

[143]  L. Nyberg,et al.  Altered deactivation in individuals with genetic risk for Alzheimer's disease , 2008, Neuropsychologia.

[144]  Claudio Babiloni,et al.  Resting state cortical rhythms in mild cognitive impairment and Alzheimer's disease: electroencephalographic evidence. , 2011, Journal of Alzheimer's disease : JAD.

[145]  Vince D. Calhoun,et al.  Alterations in Memory Networks in Mild Cognitive Impairment and Alzheimer's Disease: An Independent Component Analysis , 2006, The Journal of Neuroscience.

[146]  R. Nitrini,et al.  The dorsal raphe nucleus shows phospho‐tau neurofibrillary changes before the transentorhinal region in Alzheimer's disease. A precocious onset? , 2009, Neuropathology and applied neurobiology.

[147]  C. Jack,et al.  Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia , 2002, Neurology.

[148]  Charles DeCarli,et al.  APOE-ε4 is associated with less frontal and more medial temporal lobe atrophy in AD , 1999, Neurology.

[149]  Amy L. Shelton,et al.  Altered medial temporal lobe responses during visuospatial encoding in healthy APOE*4 carriers , 2008, Neurobiology of Aging.

[150]  J. Ashford,et al.  Modeling the time-course of Alzheimer dementia , 2001, Current psychiatry reports.

[151]  P. Rossini,et al.  White‐matter lesions along the cholinergic tracts are related to cortical sources of EEG rhythms in amnesic mild cognitive impairment , 2009, Human brain mapping.

[152]  J. Quinn,et al.  Changes in premorbid brain volume predict Alzheimer’s disease pathology , 2003, Neurology.

[153]  K. Kantarci.  1H magnetic resonance spectroscopy in dementia. , 2007, The British journal of radiology.

[154]  C. Jack,et al.  Comparison of memory fMRI response among normal, MCI, and Alzheimer’s patients , 2003, Neurology.

[155]  P. Basser,et al.  Toward a quantitative assessment of diffusion anisotropy , 1996, Magnetic resonance in medicine.

[156]  Peter J Bayley,et al.  P300 energy loss in aging and Alzheimer's disease. , 2011, Journal of Alzheimer's disease : JAD.

[157]  E. Maguire,et al.  The Human Hippocampus and Spatial and Episodic Memory , 2002, Neuron.

[158]  Maija Pihlajamäki,et al.  Increased fMRI responses during encoding in mild cognitive impairment , 2007, Neurobiology of Aging.

[159]  Sterling C. Johnson,et al.  Mapping the structural brain changes in Alzheimer's disease: the independent contribution of two imaging modalities. , 2011, Journal of Alzheimer's disease : JAD.

[160]  B. Teter,et al.  Neuroplasticity in Alzheimer's disease , 2002, Journal of neuroscience research.

[161]  Richard B. Buxton,et al.  Resting-state BOLD networks versus task-associated functional MRI for distinguishing Alzheimer's disease risk groups , 2009, NeuroImage.

[162]  Chris Frost,et al.  Short echo time proton magnetic resonance spectroscopy in Alzheimer's disease: a longitudinal multiple time point study. , 2010, Brain : a journal of neurology.

[163]  Claudio Babiloni,et al.  Disease tracking markers for Alzheimer's disease at the prodromal (MCI) stage. , 2011, Journal of Alzheimer's disease : JAD.

[164]  D. Snowdon,et al.  Age, Education, and Changes in the Mini‐Mental State Exam Scores of Older Women: Findings from the Nun Study , 1996, Journal of the American Geriatrics Society.

[165]  A. Fagan,et al.  APOE predicts amyloid‐beta but not tau Alzheimer pathology in cognitively normal aging , 2010, Annals of neurology.

[166]  E. Boerwinkle,et al.  APOE genotype and cognitive decline in a middle-aged cohort , 2005, Neurology.

[167]  D. Schacter,et al.  Medial temporal lobe activations in fMRI and PET studies of episodic encoding and retrieval , 1999, Hippocampus.

[168]  David H. Cribbs,et al.  Aβ Immunotherapy Leads to Clearance of Early, but Not Late, Hyperphosphorylated Tau Aggregates via the Proteasome , 2004, Neuron.

[169]  C. Jack,et al.  MRI correlates of neurofibrillary tangle pathology at autopsy , 2008, Neurology.

[170]  Sven Haller,et al.  Principles of classification analyses in mild cognitive impairment (MCI) and Alzheimer disease. , 2011, Journal of Alzheimer's disease : JAD.

[171]  B L Miller,et al.  Cerebrovascular and brain morphologic correlates of mild cognitive impairment in the National Heart, Lung, and Blood Institute Twin Study. , 2001, Archives of neurology.

[172]  Linda Zhang,et al.  Efficacy of voxel-based morphometry with DARTEL and standard registration as imaging biomarkers in Alzheimer's disease patients and cognitively normal older adults at 3.0 Tesla MR imaging. , 2011, Journal of Alzheimer's disease : JAD.

[173]  S. Black,et al.  Complexity of MRI white matter hyperintensity assessments in relation to cognition in aging and dementia from the Sunnybrook Dementia Study. , 2011, Journal of Alzheimer's Disease.

[174]  M. Essig,et al.  MRI-derived atrophy of the olfactory bulb and tract in mild cognitive impairment and Alzheimer's disease. , 2009, Journal of Alzheimer's disease : JAD.

[175]  A. Wagner,et al.  Reduced hippocampal activity during encoding in cognitively normal adults carrying the APOE ɛ4 allele , 2011, Neuropsychologia.

[176]  J. O'Brien,et al.  High resolution imaging of the medial temporal lobe in Alzheimer's disease and dementia with Lewy bodies. , 2010, Journal of Alzheimer's disease : JAD.

[177]  Brian Levine,et al.  Antisaccades: a probe into the dorsolateral prefrontal cortex in Alzheimer's disease. A critical review. , 2010, Journal of Alzheimer's disease : JAD.

[178]  P. Basser,et al.  In vivo fiber tractography using DT‐MRI data , 2000, Magnetic resonance in medicine.

[179]  Benjamin J. Shannon,et al.  Molecular, Structural, and Functional Characterization of Alzheimer's Disease: Evidence for a Relationship between Default Activity, Amyloid, and Memory , 2005, The Journal of Neuroscience.

[180]  S. Edland,et al.  Power calculations for clinical trials in Alzheimer's disease. , 2011, Journal of Alzheimer's disease : JAD.

[181]  Stavros J. Baloyannis,et al.  Brain SPECT findings of anosognosia in Alzheimer's disease. , 2010, Journal of Alzheimer's disease : JAD.

[182]  C. Lyketsos,et al.  Apolipoprotein E genotype and lifetime cognitive decline , 2008, International Psychogeriatrics.

[183]  K. Blennow,et al.  Imaging and CSF Studies in the Preclinical Diagnosis of Alzheimer's Disease , 2007, Annals of the New York Academy of Sciences.

[184]  E. Sullivan,et al.  Longitudinal decline of the neuronal marker N-acetyl aspartate in Alzheimer's disease , 2000, The Lancet.